Submit Manuscript  

Article Details

New Anti-VEGF Drugs in Ophthalmology

[ Vol. 21 , Issue. 12 ]


Claudio Campa *   Pages 1194 - 1200 ( 7 )


This review focuses on 5 new anti-VEGF drugs in the advanced stage of clinical development (i.e., phase 3): conbercept, brolucizumab, port delivery system with ranibizumab, abicipar pegol and faricimab.

Results of clinical trials and the advantages of each drug compared to the available molecules are discussed in detail.


Anti-VEGF, conbercept, brolucizumab, port delivery system, ranibizumab, abicipar pegol, faricimab.


Eye Clinic, Sant'Anna University Hospital, Ferrara

Graphical Abstract:

Read Full-Text article